Cowen analyst Ken Cacciatore lowered the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $50.00 (from $55.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE